Daily Liraglutide for Nicotine Dependence

NCT03712098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation
Weight, Body

Interventions

DRUG: Liraglutide
DRUG: Placebo
BEHAVIORAL: Smoking Cessation Counseling

Sponsor

Rebecca Ashare

Collaborators

[object Object]